PTGER3 and endometrioid adenocarcinoma: EP3 staining showed significant difference within the World Health Organization (WHO) grading in the overall cohort (p = 0.011) (Figure 1A-1D) as well as in the endometrioid adenocarcinoma subgroup (p = 0.013) (Figure 1E).